Watch Annual Conference From AnyWhere Around the World
MS talks at the 2019 Annual Conference in Limerick
Research
European Disability Strategy Consultation
The European Commission is hosting a survey consultation on the current European Disability Strategy
EMA warns that Gilenya must not be used during pregnancy
The European Medicines Agency has issued a press release recommending that Gilenya (fingolimod) not be used during pregnancy or by women of child-baring age who are not using effective contraception.
NUI Galway to Develop New Treatments for Multiple Sclerosis
New €3.9 million NUI Galway-led European consortium to train researchers in developing new treatments for Multiple Sclerosis
Carers Research Findings
Research shows online supports vital as majority of carers feel isolated in their role
MS Symptoms Research Findings
NEW Research shows that 44% of Irish people have poor understanding of the symptoms and nature of Multiple Sclerosis (MS)[1]